Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News (Page 8)
Related terms: Cancer, Prostate, Carcinoma of Prostate
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
THOUSAND OAKS, Calif., September 19, 2011, 2011 /PRNewswire/ – Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia (denosumab) as a...
FDA Approves Zytiga for Late-Stage Prostate Cancer
SILVER SPRING, Md., April 28, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat...
Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review
Paris, France – June 17, 2010 – Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for Jevtana (cabazitaxel) Injection in combination w...
FDA Approves Provenge - a Cellular Immunotherapy for Men With Advanced Prostate Cancer
SILVER SPRING, Md., April 29 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that...
FDA Approves Watson's Trelstar 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
MORRISTOWN, N.J., March 11 /PRNewswire-FirstCall/ – Watson Pharmaceuticals, Inc., today announced the U.S. Food and Drug Administration (FDA) approval of Trelstar 22.5 mg (triptorelin pamoate for...
Ask a question
To post your own question to this support group, sign in or create an account.